Table: Torii Pharmaceutical - 9-MTH parent results
Oct 31 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2024 Sep 30, 2023 Dec 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 43.33 39.13 61.20
(+10.7 pct) (+10.8 pct) (+12.0 pct)
Operating 4.66 3.21 6.70
(+45.2 pct) (-21.0 pct) (+33.1 pct)
Recurring 4.69 3.32 6.80
(+41.4 pct) (-15.4 pct) (+28.1 pct)
Net 3.53 2.37 5.10
(+48.9 pct) (-17.1 pct) (+23.8 pct)
EPS 125.43 yen 84.27 yen 181.44 yen
Ann Div 120.00 yen 120.00 yen
-Q2 div 60.00 yen 50.00 yen
-Q4 div 70.00 yen 60.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)